Skip to content

H.R. 8938 · 119th Congress (2025–2027)

Biotechnology Workforce Alignment Act of 2026

To direct the Director of the National Science Foundation to carry out activities to support biotechnology workforce pathways and alignment with Federal research investments, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 8938’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Richard McCormick (R-GA-7)
Cosponsors
5 cosponsors

1 original · 4 later

  1. Rep. Ro Khanna (D-CA-17)· Original · May 20, 2026
  2. Rep. Sarah McBride (D-DE)· Later · Jun 3, 2026
  3. Rep. Eugene Simon Vindman (D-VA-7)· Later · Jun 25, 2026
  4. Rep. Pat Harrigan (R-NC-10)· Later · Jun 30, 2026
  5. Rep. Donald G. Davis (D-NC-1)· Later · Aug 13, 2026
Policy area
Science, Technology, Communications

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Science, Space, and Technology.

    Sources

Committees

  1. HouseScience, Space, and TechnologyReferred May 20, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Biotechnology Workforce Alignment Act of 2026

    Display title, Short title · Introduced in House

  2. To direct the Director of the National Science Foundation to carry out activities to support biotechnology workforce pathways and alignment with Federal research investments, and for other purposes.

    Official title · Introduced in House